Marleen Kok, MD, PhD, on Luminal Breast Cancer: Immunotherapy Strategies

Posted: Monday, November 5, 2018

Marleen Kok, MD, PhD, of The Netherlands Cancer Institute, discusses some possible solutions to the problem that only a few patients with luminal breast cancer respond to current immunotherapies: giving immunotherapy earlier in the course of the disease or using combination immunotherapies.